Company / Inventory
Incyte Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$101.1M
FY2025
5-year range
$27.9M / $101.1M
FY2021-FY2025
Trend
+71.7%
vs FY2024
Sector context
#45 of 105
Health Care
What the data says
At $101M, Incyte's inventory ranks #45 of 105 in the Health Care sector. Improved from $63M to $101M over the past 2 years.
Based on SEC 10-K filings.
$101M in FY2025 with a 5-year CAGR of +43.8%.
Improved from $63M to $101M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +34.0%
- 5-Year CAGR
- +43.8%
- 10-Year CAGR
- -
Sector benchmark
#45 of 105 in Health CareTop 43% of 105This company $101.1M Sector average $885.3M
▼
-88.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +43.8%, indicating consistent growth.
- In FY2025, inventory increased 71.7% year-over-year.
- Ranks #45 out of 105 companies in the Health Care sector.
- Lowest inventory in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $101.1M | +71.7% |
| FY2024 | $58.9M | -6.5% |
| FY2023 | $63.0M | +50.0% |
| FY2022 | $42.0M | +50.5% |
| FY2021 | $27.9M | +69.9% |
| FY2020 | $16.4M | +44.1% |
| FY2019 | $11.4M | +63.6% |
| FY2018 | $7.0M | +7.5% |
| FY2017 | $6.5M | +57.9% |
| FY2016 | $4.1M | +130.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026